Guidance

Mandatory healthcare associated infection surveillance: data quality statement

Data quality statements for the mandatory surveillance of healthcare associated infection (HCAI).

• From: UK Health Security Agency
• Published: 7 April 2016
• Last updated: 9 June 2022 — See all updates

Documents

Mandatory healthcare associated infection surveillance: data quality statement for April 2019 to March 2020

Ref: UKHSA publication gateway number GOV-12247

PDF, 765 KB, 37 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

These documents describe many of the aspects of quality assurance (QA) surrounding the routine publication of data for the mandatory surveillance of HCAI (MRSA, MSSA, and Gram-negative bacteraemia and C. difficile infection).

We will review and update these statements annually, towards the end of each financial year.

Previous reports were published by Public Health England.

Published 7 April 2016
Last updated 9 June 2022 + show all updates

1. 9 June 2022

   Archived older reports and added 2022 report.

2. 4 January 2021

   Added 2020 statement.

3. 27 September 2019

   Added updated data quality statement.

4. 5 June 2018

   Replaced document with 'Mandatory Healthcare Associated Infection Surveillance: Data Quality Statement, April 2018'

5. 3 August 2017

   Updated version, June 2017.

6. 7 April 2016

   First published.